- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Tenofovir alafenamide, emtricitabine and rilpivirine fixed dose combination – November 2016
Tenofovir alafenamide, emtricitabine and rilpivirine fixed dose combination tablet containing tenofovir alafenamide 25 mg, emtricitabine 200 mg and rilpivirine 25 mg, Odefsey®
Last updated
4 July 2018